23:58:47 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-29 Kvartalsrapport 2024-Q3
2024-08-30 Kvartalsrapport 2024-Q2
2024-05-31 Kvartalsrapport 2024-Q1
2024-05-29 Ordinarie utdelning POLAR 0.00 SEK
2024-05-28 Årsstämma 2024
2024-02-23 Bokslutskommuniké 2023
2023-11-24 Kvartalsrapport 2023-Q3
2023-09-08 Extra Bolagsstämma 2023
2023-08-25 Kvartalsrapport 2023-Q2
2023-05-26 Kvartalsrapport 2023-Q1
2023-05-17 Årsstämma 2023
2023-05-05 Ordinarie utdelning POLAR 0.00 SEK
2023-03-13 Extra Bolagsstämma 2022
2023-02-24 Bokslutskommuniké 2022
2022-11-25 Kvartalsrapport 2022-Q3
2022-08-26 Kvartalsrapport 2022-Q2
2022-05-27 Kvartalsrapport 2022-Q1
2022-05-06 Ordinarie utdelning POLAR 0.00 SEK
2022-05-05 Årsstämma 2022
2022-02-25 Bokslutskommuniké 2021
2021-11-26 Kvartalsrapport 2021-Q3
2021-08-27 Kvartalsrapport 2021-Q2
2021-05-28 Kvartalsrapport 2021-Q1
2021-05-06 Ordinarie utdelning POLAR 0.00 SEK
2021-05-05 Årsstämma 2021
2021-02-26 Bokslutskommuniké 2020
2020-11-27 Kvartalsrapport 2020-Q3
2020-08-28 Kvartalsrapport 2020-Q2
2020-07-01 Ordinarie utdelning POLAR 0.00 SEK
2020-06-30 Årsstämma 2020
2020-05-29 Kvartalsrapport 2020-Q1
2020-02-28 Bokslutskommuniké 2019
2020-02-14 Extra Bolagsstämma 2020
2019-10-23 Kvartalsrapport 2019-Q3
2019-07-24 Kvartalsrapport 2019-Q2
2019-05-07 Split POLAR 16:1
2019-04-26 Kvartalsrapport 2019-Q1
2019-03-19 Årsstämma 2019
2019-02-04 Ordinarie utdelning POLAR 0.00 SEK
2019-02-01 Bokslutskommuniké 2018

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
Polarcool är verksamt inom medicinteknik. Idag är bolaget inriktade mot att produkter och lösningar inriktade för skador inom sport och aktivitet. Störst fokus återfinns inom forskning och utveckling av produkter som används vid behandling av hjärnskador vid exempelvis boxning, rugby och amerikansk fotboll. Verksamhet innehas på global nivå, med störst närvaro inom den europeiska marknaden.
2024-02-15 10:01:00

The med-tec company PolarCool AB (publ.) has been invited to attend the FIM Medical Summit and Congress, on February 17th, and 18th 2024 in France. PolarCool's CEO Erik Andersson will present PolarCap® to the FIM Medical Congress on February 17th and showcase PolarCap® at the Medical Summit on the 18th.

PolarCool has been invited by FIM Medical Director Dr. David McManus to present the company's product PolarCap® System which alleviates the effects of concussions.

The inaugural FIM Medical Summit coincides with the 2024 FIM Commissions Conference and is designed as a platform for FIM medical professionals to convene, exchange invaluable insights, and disseminate best practices, the summit will cover a wide array of critical topics, including concussion protocols.

The summit will be attended by FIM MotoGPTM and FIM Superbike World Championship Chief Medical Officers (CMOs) and Commission Members, as well as CMOs and promoters across various motorcycle sports disciplines. Currently, over a hundred participants have registered to attend, representing a diverse spectrum of expertise and experience within the industry.

PolarCool's CEO Erik Andersson comments;

-The invitation from Dr. David McManus to present PolarCap® at the FIM Medical Congress and showcase the device at the Medical Summit is a tremendous honor. We view this an important opportunity to introduce PolarCap® to a new market, but also as a catalyst for fostering collaborations and driving meaningful discussions surrounding concussion management and treatment with PolarCap®. Several of the participants are not only active in motorsport but have assignments in other sports.

PolarCool develops the product PolarCap®, which alleviates the effects of concussions. The primary customers are sports clubs and facilities in ice hockey, rugby, football and handball, but also other sports with an increased risk of concussion.